Skip to main content

PMGC Holdings Inc.

corporate_fare Company Profile

PMGC Holdings Inc.

ELAB·NASDAQ·Life Sciences·CIK 0001840563

As of December 31, 2025, the company manages and operates a diverse portfolio of four wholly owned subsidiaries across the medical aesthetics and biopharmaceutical sectors. Northstrive Biosciences Inc. is a biopharmaceutical company that develops and acquires aesthetic medicines and therapeutic products. Its lead asset, EL-22, uses an engineered probiotic approach to address muscle preservation during weight loss treatments, including those using GLP-1 receptor agonists. PMGC Capital LLC is a multi-strategy investment firm that focuses on direct investments, strategic lending, and acquiring undervalued companies and assets across various markets. Pacific Sun Packaging, Inc. is a specialty packaging provider that offers high-precision, component-level packaging solutions for the electronics and information technology hardware industries. The company designs and supplies custom-engineered protective packaging for components such as CPUs, DIMMs, SO-DIMMs, SSDs, HDDs, and fiber-optic transceivers, serving customers in the semiconductor, data center, and networking equipment supply chains. AGA Precision Systems LLC is a specialized CNC machine shop that performs high-tolerance milling, turning, mold manufacturing, and machining of complex metals like titanium and Inconel. It serves customers in the aerospace, defense, and industrial sectors by delivering precision components. On January 16, 2025, the company completed the divestiture of assets related to its former Elevai Skincare Inc. business, which previously specialized in physician-dispensed skincare products.

PMGC Holdings Inc. (NASDAQ:ELAB) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 58 items for ELAB at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-02, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 9 rated 8 or above. Recent SEC coverage for ELAB spans 8-K, 10-Q, SCHEDULE 13D, SCHEDULE 13D/A.

Recent high-impact activity:

  • PMGC Authorizes 1.5B Shares and Formalizes AI Drug Expansion Program
  • NorthStrive Biosciences Expands AI Drug Discovery with Yuva, Targets Lead Nomination
  • PMGC Ends Arizona Acquisition LOI, Inks Orbit2Orbit Space Partnership Term Sheet
  • PMGC Holdings Terminates Acquisition LOI After Due Diligence
  • PMGC Holdings Announces 1-for-10 Reverse Split Effective August 21

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$590.08K
Net Income
-$7.75M
Op. Cash Flow
-$5.93M
Free Cash Flow
-$6.38M
Gross Profit
$185.31K
Cash & Equivalents
$5.4M
Debt / Equity
0.00×
Net Margin
-13.13×
Shares Outstanding
80.7K sh
Source: 10-K · filed 2026-03-30 · accession 0001213900-26-035937

Dilution Risk

Low risk

Filing-implied dilution signals for ELAB, detected from its recent SEC filings · based on capital-structure filings through 2026-04-27.

1 recent capital raise

Equity Drawdown Finalized · Dilutive Terms

⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with E →
$4.58 +0.06% today
52-week range · as of 2026-09-02 $4.58 – $2671.2
Market cap
$3.66M
Volume
11.4K (0.2× avg)
3-mo avg 49.3K
Live data · 2026-09-14 00:01 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ELAB - Latest Insights

ELAB
Sep 02, 2026, 5:04 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.20
Real-time Price: $4.58 info
Change: -$0.620 (-12%) info
Market Cap: $3.659M info
ELAB
Sep 01, 2026, 7:45 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $5.23
Real-time Price: $4.58 info
Change: -$0.650 (-12%) info
Market Cap: $3.659M info
ELAB
Aug 27, 2026, 5:26 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.80
Real-time Price: $4.58 info
Change: -$1.22 (-21%) info
Market Cap: $3.659M info
ELAB
Aug 26, 2026, 8:17 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $5.24
Real-time Price: $4.58 info
Change: -$0.660 (-13%) info
Market Cap: $3.659M info
ELAB
Aug 19, 2026, 11:45 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.7868
Real-time Price: $4.58 info
Change: Reverse Stock Split info
Market Cap: $3.659M info
ELAB
Aug 14, 2026, 9:55 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.940
Real-time Price: $4.58 info
Change: Reverse Stock Split info
Market Cap: $3.659M info
ELAB
Aug 14, 2026, 9:31 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.9327
Real-time Price: $4.58 info
Change: Reverse Stock Split info
Market Cap: $3.659M info
ELAB
Jul 29, 2026, 3:54 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.8775
Real-time Price: $4.58 info
Change: Reverse Stock Split info
Market Cap: $3.659M info
ELAB
Jul 13, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.03
Real-time Price: $4.58 info
Change: Reverse Stock Split info
Market Cap: $3.659M info
ELAB
Jul 07, 2026, 5:18 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.20
Real-time Price: $4.58 info
Change: Reverse Stock Split info
Market Cap: $3.659M info
ELAB
Jul 06, 2026, 7:32 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $1.33
Real-time Price: $4.58 info
Change: Reverse Stock Split info
Market Cap: $3.659M info
ELAB
Jul 01, 2026, 7:33 AM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $1.57
Real-time Price: $4.58 info
Change: Reverse Stock Split info
Market Cap: $3.659M info
ELAB
Jul 01, 2026, 7:31 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.28
Real-time Price: $4.58 info
Change: Reverse Stock Split info
Market Cap: $3.659M info
ELAB
Jun 18, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.48
Real-time Price: $4.58 info
Change: Reverse Stock Split info
Market Cap: $3.659M info
ELAB
Jun 08, 2026, 5:08 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.56
Real-time Price: $4.58 info
Change: Reverse Stock Split info
Market Cap: $3.659M info
ELAB
Jun 08, 2026, 7:31 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.79
Real-time Price: $4.58 info
Change: Reverse Stock Split info
Market Cap: $3.659M info
ELAB
Jun 05, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.52
Real-time Price: $4.58 info
Change: Reverse Stock Split info
Market Cap: $3.659M info
ELAB
Jun 03, 2026, 4:01 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
Price at Filing: $1.81
Real-time Price: $4.58 info
Change: Reverse Stock Split info
Market Cap: $3.659M info
ELAB
Jun 03, 2026, 4:01 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $1.81
Real-time Price: $4.58 info
Change: Reverse Stock Split info
Market Cap: $3.659M info
ELAB
Jun 01, 2026, 7:35 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $1.89
Real-time Price: $4.58 info
Change: Reverse Stock Split info
Market Cap: $3.659M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets